23andMe to build target discovery group around Scheller

23andMe Inc. (Mountain View, Calif.) announced it will launch a therapeutics group led by newly appointed CSO Richard Scheller, the former EVP of research and early development at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY).

President Andy Page said the team will spend the first 3 to 9 months mining the company's database to identify novel drug targets. ...